Read Full Article
AmerisourceBergen Corporation today announced that, following Richard C. Gozon’s retirement as Chairman of the Board at the annual meeting of stockholders in March 2016, Steven H...
With his unparalleled knowledge of the Company and industry, Steve is uniquely positioned to lead AmerisourceBergen as it moves forward and to fulfill the Company's long-term strategic objectives and expansion into new markets. His strategy has built, and will continue to build, value for shareholders.
Jane's integrity, experience as a director of public companies, including at Cigna Corporation, AstraZeneca PLC and Cubist Pharmaceuticals, Inc., commitment to governance best practices and leadership of the Governance and Nominating Committee made her a clear choice to take on the role of Lead Independent Director.
I want to thank Dick for his extraordinary dedication to AmerisourceBergen and the outstanding leadership and guidance that he has provided as Chairman. While we will miss him greatly, Dick's legacy will be lasting.
I am grateful that Jane has agreed to assume the position of Lead Independent Director following Dick's retirement. She brings tremendous commitment to her responsibilities on the Board, vital healthcare, health policy and regulatory expertise, and substantial management experience.